87 related articles for article (PubMed ID: 31957817)
1. Exosomes transferring long non-coding RNA FAL1 to regulate ovarian cancer metastasis through the PTEN/AKT signaling pathway.
Zhang Q; Len TY; Zhang SX; Zhao QH; Yang LH
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):43-54. PubMed ID: 31957817
[TBL] [Abstract][Full Text] [Related]
2. Regulations of Exosomal-Transmitted
Zhou F; Xu X; Wei W; Chen X; Sun L
Discov Med; 2023 Oct; 35(178):877-886. PubMed ID: 37811626
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA FAL1 regulated cell proliferation through Akt pathway via targeting PDK1 in esophageal cancer cells.
Liang XS; Sun Y; Liu T
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5214-5222. PubMed ID: 30178844
[TBL] [Abstract][Full Text] [Related]
4. MATN2 overexpression suppresses tumor growth in ovarian cancer via PTEN/PI3K/AKT pathway.
Liu J; Zhang J; Zhang Y; Yang B; Liu H; Chen Y
Funct Integr Genomics; 2024 Apr; 24(2):71. PubMed ID: 38568332
[TBL] [Abstract][Full Text] [Related]
5. β-Sitosterol targets ASS1 for Nrf2 ubiquitin-dependent degradation, inducing ROS-mediated apoptosis via the PTEN/PI3K/AKT signaling pathway in ovarian cancer.
Wang H; Liu J; Zhang Z; Peng J; Wang Z; Yang L; Wang X; Hu S; Hong L
Free Radic Biol Med; 2024 Mar; 214():137-157. PubMed ID: 38364944
[TBL] [Abstract][Full Text] [Related]
6. CAF-derived exosomal lncRNA FAL1 promotes chemoresistance to oxaliplatin by regulating autophagy in colorectal cancer.
Zhu S; Mao J; Zhang X; Wang P; Zhou Y; Tong J; Peng H; Yang B; Fu Q
Dig Liver Dis; 2024 Feb; 56(2):330-342. PubMed ID: 37400281
[TBL] [Abstract][Full Text] [Related]
7. Tumour-derived exosome SNHG17 induced by oestrogen contributes to ovarian cancer progression via the CCL13-CCR2-M2 macrophage axis.
Liang H; Geng S; Wang Y; Fang Q; Xin Y; Li Y
J Cell Mol Med; 2024 May; 28(9):e18315. PubMed ID: 38680032
[TBL] [Abstract][Full Text] [Related]
8. LINC00184 silencing inhibits glycolysis and restores mitochondrial oxidative phosphorylation in esophageal cancer through demethylation of PTEN.
Li W; Huang K; Wen F; Cui G; Guo H; He Z; Zhao S
EBioMedicine; 2019 Jun; 44():298-310. PubMed ID: 31201145
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3/Rab proteins.
Dorayappan KDP; Wanner R; Wallbillich JJ; Saini U; Zingarelli R; Suarez AA; Cohn DE; Selvendiran K
Oncogene; 2018 Jul; 37(28):3806-3821. PubMed ID: 29636548
[TBL] [Abstract][Full Text] [Related]
10. Shikonin reduces M2 macrophage population in ovarian cancer by repressing exosome production and the exosomal galectin 3-mediated β-catenin activation.
Wang M; Sun Y; Gu R; Tang Y; Han G; Zhao S
J Ovarian Res; 2024 May; 17(1):101. PubMed ID: 38745186
[TBL] [Abstract][Full Text] [Related]
11. PINK1-PTEN axis promotes metastasis and chemoresistance in ovarian cancer via non-canonical pathway.
Zheng F; Zhong J; Chen K; Shi Y; Wang F; Wang S; Tang S; Yuan X; Shen Z; Tang S; Xia D; Wu Y; Lu W
J Exp Clin Cancer Res; 2023 Nov; 42(1):295. PubMed ID: 37940999
[TBL] [Abstract][Full Text] [Related]
12. PTEN-restoration abrogates brain colonisation and perivascular niche invasion by melanoma cells.
Wang S; Riedstra CP; Zhang Y; Anandh S; Dudley AC
Br J Cancer; 2024 Mar; 130(4):555-567. PubMed ID: 38148377
[TBL] [Abstract][Full Text] [Related]
13. Patient-Derived Exosomes as siRNA Carriers in Ovarian Cancer Treatment.
Shimizu A; Sawada K; Kobayashi M; Oi Y; Oride T; Kinose Y; Kodama M; Hashimoto K; Kimura T
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672564
[TBL] [Abstract][Full Text] [Related]
14. Getting to know ovarian cancer: Focusing on the effect of LncRNAs in this cancer and the effective signaling pathways.
Alzahrani AA; Almajidi YQ; Jasim SA; Hjazi A; Olegovich BD; Alkhafaji AT; Abdulridui HA; Ahmed BA; Alawadi A; Alsalamy A
Pathol Res Pract; 2024 Feb; 254():155084. PubMed ID: 38244434
[TBL] [Abstract][Full Text] [Related]
15. Ascites exosomal lncRNA PLADE enhances platinum sensitivity by inducing R-loops in ovarian cancer.
Liu H; Deng S; Yao X; Liu Y; Qian L; Wang Y; Zhang T; Shan G; Chen L; Zhou Y
Oncogene; 2024 Mar; 43(10):714-728. PubMed ID: 38225339
[TBL] [Abstract][Full Text] [Related]
16. Identification of SAA1 as a novel metastasis marker in ovarian cancer and development of a graphene-based detection platform for early assessment.
Zhao Y; Chen Y; Wan Q; Xiao C; Guo Z; Du X; Hu Y; Zheng A; Cao Z
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16391-16406. PubMed ID: 37707574
[TBL] [Abstract][Full Text] [Related]
17. LINC02489 with m6a modification increase paclitaxel sensitivity by inhibiting migration and invasion of ovarian cancer cells.
Xie Y; Wang L; Luo Y; Chen H; Yang Y; Shen Q; Cao G
Biotechnol Genet Eng Rev; 2023 Jan; ():1-15. PubMed ID: 36703541
[TBL] [Abstract][Full Text] [Related]
18. Epiphycan Predicts Poor Outcomes and Promotes Metastasis in Ovarian Cancer.
Deng L; Wang D; Chen S; Hu W; Zhang R
Front Oncol; 2021; 11():653782. PubMed ID: 34888227
[TBL] [Abstract][Full Text] [Related]
19. Tumor Targeting
Ijabi J; Ijabi R; Roozehdar P; Kaminsky ZA; Moradi-Sardareh H; Tehranian N; Ahmed N
Microrna; 2024 Jan; ():. PubMed ID: 38243930
[TBL] [Abstract][Full Text] [Related]
20. Dicalcin suppresses invasion and metastasis of mammalian ovarian cancer cells by regulating the ganglioside-Erk1/2 axis.
Miwa N; Hanaue M; Aoba K; Saito R; Takamatsu K
Commun Biol; 2023 Oct; 6(1):1015. PubMed ID: 37803211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
